These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 27041002)
21. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer. Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287 [TBL] [Abstract][Full Text] [Related]
22. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients? Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162 [TBL] [Abstract][Full Text] [Related]
23. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Goyal A; Newcombe RG; Chhabra A; Mansel RE Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117 [TBL] [Abstract][Full Text] [Related]
24. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema. Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174 [TBL] [Abstract][Full Text] [Related]
25. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
26. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Goyal A; Newcombe RG; Chhabra A; Mansel RE; Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308 [TBL] [Abstract][Full Text] [Related]
27. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Albertini JJ; Lyman GH; Cox C; Yeatman T; Balducci L; Ku N; Shivers S; Berman C; Wells K; Rapaport D; Shons A; Horton J; Greenberg H; Nicosia S; Clark R; Cantor A; Reintgen DS JAMA; 1996 Dec; 276(22):1818-22. PubMed ID: 8946902 [TBL] [Abstract][Full Text] [Related]
28. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes. Plecha D; Bai S; Patterson H; Thompson C; Shenk R Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365 [TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy. Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504 [TBL] [Abstract][Full Text] [Related]
30. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review. Seyednejad N; Kuusk U; Wiseman SM Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187 [TBL] [Abstract][Full Text] [Related]
31. Axillary reverse mapping using a fluorescence imaging system in breast cancer. Noguchi M; Noguchi M; Nakano Y; Ohno Y; Kosaka T J Surg Oncol; 2012 Mar; 105(3):229-34. PubMed ID: 21913193 [TBL] [Abstract][Full Text] [Related]
32. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases. Boler DE; Uras C; Ince U; Cabioglu N Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110 [TBL] [Abstract][Full Text] [Related]
33. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
34. Axillary reverse mapping (ARM): where to go. Shao X; Sun B; Shen Y Breast Cancer; 2019 Jan; 26(1):1-10. PubMed ID: 29961238 [TBL] [Abstract][Full Text] [Related]
35. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Nos C; Lesieur B; Clough KB; Lecuru F Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570 [TBL] [Abstract][Full Text] [Related]
36. Prospective study evaluating oncological safety of axillary reverse mapping. Schunemann E; Dória MT; Silvestre JB; Gasperin P; Cavalcanti TC; Budel VM Ann Surg Oncol; 2014 Jul; 21(7):2197-202. PubMed ID: 24599413 [TBL] [Abstract][Full Text] [Related]
37. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer. Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806 [TBL] [Abstract][Full Text] [Related]
38. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment. Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044 [TBL] [Abstract][Full Text] [Related]
39. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
40. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]